DSGN | Design TherapeuticsNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history

$10.34
+$0.19 (+1.87%)

Design Therapeutics (DSGN) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2022.

Right now the daily is the chart to watch. The 50 SMA has sat above the 200 since Sep 2025, but the two have been closing on each other and a death cross is projected within 10 bars. On both the daily and the 4-hour, price sits below the 50 and the 200; on the weekly it is between the two.

Timeframe summary

Daily as of 3 Nov 16:00 ET

Price
below both $10.34 vs 50 $12.46 / 200 $12.18
Projection
Death cross projected in 4 bars
Test
No active test
Last cross
Golden cross 10 Sep 2025 ยท projected 27 bars out

Weekly as of 30 Oct 16:00 ET

Price
between the two $10.68 vs 50 $11.63 / 200 $6.46
Projection
No cross projected
Test
No active test
Last cross
Golden cross week of 6 Apr 2026 ยท projected 23 bars out

4-hour as of 3 Nov 16:00 ET

Price
below both $10.34 vs 50 $11.02 / 200 $12.99
Projection
No cross projected
Test
No active test
Last cross
Death cross 9 Oct 2026 ยท projected 28 bars out

Cross history

16
crosses on record since 2022
9 golden7 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
9 Oct 2026Death4-hour28 bars outNot tested
30 Jun 2026Golden4-hour23 bars outNot tested
17 Jun 2026Death4-hour28 bars out1 bar cross test
week of 6 Apr 2026Golden moderateweekly23 bars outNot tested
10 Sep 2025Golden moderatedaily27 bars outNot tested

About DSGN

ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$7M
4-hour coverageYes, since Oct 2025
History on recordSince 2022
SectorHealthcare
Cap bandsmall

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.